Uniformity of captopril benefit in the SAVE study: subgroup analysis
LA Moye, MA Pfeffer, CC Wun, BR Davis… - European heart …, 1994 - academic.oup.com
Abstract The Survival and Ventricular Enlargement (SAVE) Study demonstrated that long-
term administration of the angiotensin-converting enzyme inhibitor captopril to recent …
term administration of the angiotensin-converting enzyme inhibitor captopril to recent …
The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
MA Pfeffer - Herz, 1993 - europepmc.org
Myocardial infarction increases the risk of subsequent cardiovascular events (eg, heart
failure or another myocardial infarction) among survivors as compared with the general …
failure or another myocardial infarction) among survivors as compared with the general …
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
BACKGROUND In the Survival and Ventricular Enlargement (SAVE) trial, recurrent
myocardial infarction (MI) was the most important predictor of a poor outcome and conferred …
myocardial infarction (MI) was the most important predictor of a poor outcome and conferred …
Cost-effectiveness of captopril therapy after myocardial infarction
J Tsevat, D Duke, L Goldman, MA Pfeffer… - Journal of the American …, 1995 - Elsevier
OBJECTIVES.: This study sought to assess the cost-effectiveness of captopril therapy for
survivors of myocardial infarction. BACKGROUND.: The recent randomized, controlled …
survivors of myocardial infarction. BACKGROUND.: The recent randomized, controlled …
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement …
MA Pfeffer, E Braunwald, LA Moyé… - New England journal …, 1992 - Mass Medical Soc
Background. Left ventricular dilatation and dysfunction after myocardial infarction are major
predictors of death. In experimental and clinical studies, long-term therapy with the …
predictors of death. In experimental and clinical studies, long-term therapy with the …
Captopril: a review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease
GL Plosker, D McTavish - Drugs & Aging, 1995 - Springer
Synopsis Captopril is an angiotensin converting enzyme (ACE) inhibitor which has been
used extensively in the treatment of patients with hypertension and congestive heart failure …
used extensively in the treatment of patients with hypertension and congestive heart failure …
Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from …
WH Van Gilst, JH Kingma, KH Peels… - Journal of the American …, 1996 - Elsevier
Objectives. In this study we sought to investigate the effect of intervention with captopril
within 6 h of the onset of myocardial infarction on left ventricular volume and clinical …
within 6 h of the onset of myocardial infarction on left ventricular volume and clinical …
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …
mortality and cardiovascular morbidity among patients with myocardial infarction …
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information …
MSJ Sutton, MA Pfeffer, L Moye, T Plappert… - Circulation, 1997 - Am Heart Assoc
Background We quantified cardiovascular death and/or left ventricular (LV) dilatation in
patients from the SAVE trial to determine whether dilatation continued beyond 1 year …
patients from the SAVE trial to determine whether dilatation continued beyond 1 year …
Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing
SG Ball, AS Hall, GD Murray - Journal of the American College of …, 1995 - Elsevier
A number of major studies have examined the impact of angiotensin-converting enzyme
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …